3'-(三氟甲基)-[1,1'-联苯]-2-羧酸 | 408367-99-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3'-(三氟甲基)-[1,1'-联苯]-2-羧酸
• 中文别名: 3'-（三氟甲基）-[1,1'-联苯]-2-羧酸
• 英文名称: 2-(3-trifluoromethyl)phenylbenzoic acid
• 英文别名: 3'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxylic acid；3'-(trifluoromethyl)biphenyl-2-carboxylic acid；3'-(trifluoromethyl)-2-biphenylcarboxylic acid；2-[3-(trifluoromethyl)phenyl]benzoic acid
• CAS: 408367-99-7
• 化学式: C₁₄H₉F₃O₂
• mdl: MFCD04039234
• 分子量: 266.219
• InChiKey: XBWKOWZGGKOHBN-UHFFFAOYSA-N

物化性质

• 沸点：
  350.0±42.0 °C(Predicted)
• 密度：
  1.326±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.071
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2916399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(3-Trifluoromethylphenyl)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(3-Trifluoromethylphenyl)benzoic acid
CAS number: 408367-99-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H9F3O2
Molecular weight: 266.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3'-(三氟甲基)-[1,1'-联苯]-2-羧酸 在 碘苯二乙酸 、 potassium acetate 、 palladium diacetate 、 N-乙酰甘氨酸 作用下， 以 叔丁醇 为溶剂， 反应 12.0h， 以64%的产率得到2-(trifluoromethyl)-6H-benzo[c]chromen-6-one
  参考文献：
  名称：

  Pd催化的C–H漆基化方便地合成联芳基内酯和总合成大麻酚

  摘要：

  已开发出一种实用的Pd（II）/ Pd（IV）催化的羧基定向C–H活化/ C–O环化反应来构建联芳基内酯。该新反应的合成效用在天然经济的大麻素从市售原料中进行了原子经济且操作方便的全合成中得到了证明，其中新开发的方法用于两个关键步骤。

  DOI：

  10.1021/ol400877q
• 作为产物：
  描述：

  2-碘苯甲酸甲酯 在 bis-triphenylphosphine-palladium(II) chloride 、 水 、 sodium carbonate 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 生成 3'-(三氟甲基)-[1,1'-联苯]-2-羧酸
  参考文献：
  名称：

  钯催化的 2-芳基苯甲酰氟的分子内芳香族 C-H 酰化

  摘要：

  描述了使用 Pd(OAc) 2 /PCy 3系统进行酰氟的催化分子内环化。广泛的 2-芳基苯甲酰氟衍生物可用作芴酮前体，反应通过芳族 C-H 键与酰基 C-F 键之间的分子内偶联进行。该反应可用于茚并芴二酮衍生物的合成和其他五元环分子的构建。

  DOI：

  10.1246/bcsj.20210148

文献信息

• Benzamide compounds as apo b secretion inhibitors
  申请人：——

  公开号：US20040058903A1

  公开（公告）日：2004-03-25

  The present invention relates to compounds of the formula (I) wherein R 1 and R 2 are each independently lower alkyl lower alkenyl, acyl, amino, lower alkoxy, lower cycloalkyloxy, aryl, aryloxy, sulfooxy, mercapto, sulfo, hydrogen, halogen, nitro, cyano or hydroxy, or may form a ring structure; Q 1 is N or CH; L is optionally substituted unsaturated 3 to 10-membered heterocyclic group; X is optionally substituted monocyclic arylene or monocyclic heteroarylene; Y is -(A 1 ) m -(A 2 ) n -(A 4 ) k -; Z is directbond, —CH2-, —NH— or —O—; and R is hydrogen or lower alkyl, or a salt thereof The compounds of the present invention inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B.

  本发明涉及式(I)的化合物，其中R1和R2分别独立地为较低的烷基较低的烯基、酰基、氨基、较低的烷氧基、较低的环烷氧基、芳基、芳氧基、磺氧基、巯基、磺基、氢、卤素、硝基、氰基或羟基，或者可以形成环结构；Q1为N或CH；L是可选的取代的不饱和的3到10元杂环基；X是可选的取代的单环芳基或单环杂芳基；Y是-(A1)m-(A2)n-(A4)k-；Z是直键，-CH2-，-NH-或-O-；R为氢或较低的烷基，或其盐。本发明的化合物抑制载脂蛋白B（Apo B）的分泌，并可用作预防和治疗由于载脂蛋白B循环水平升高而导致的疾病或症状的药物。
• General and Practical Carboxyl-Group-Directed Remote CH Oxygenation Reactions of Arenes
  作者：Yang Wang、Anton V. Gulevich、Vladimir Gevorgyan

  DOI：10.1002/chem.201303511

  日期：2013.11.18

  Two methods for remote aromatic CH oxygenation reactions, have been developed. Method 1, the Cu‐catalyzed oxygenation reaction, is highly efficient for cyclization of electron‐neutral and electron‐rich biaryl carboxylic acids into 3,4‐benzocoumarins. Method 2, the K2S2O8‐mediated oxygenation reaction, is more general and practical for cyclization of substrates with electron‐donating and ‐withdrawing

  已经开发了两种用于远程芳族 C  H 氧化反应的方法。方法 1，即 Cu 催化的氧化反应，对于将电子中性和富电子的联芳基羧酸环化为 3,4-苯香豆素非常有效。方法 2，K 2 S 2 O 8介导的氧化反应，对于具有给电子和吸电子基团的底物的环化更为通用和实用（见方案）。
• Use of therapeutic benzamide derivatives
  申请人：——

  公开号：US20040044008A1

  公开（公告）日：2004-03-04

  The invention relates to the use of therapeutic benzamide compounds of formula (I). As microsomal triglyceride transfer protein (MTP) inhibitors for treating obesity and post-prandial hyperlipemia. 1

  本发明涉及治疗用苯甲酰胺化合物（I）的使用。作为微粒体甘油三酯转移蛋白（MTP）抑制剂，用于治疗肥胖和餐后高脂血症。
• AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
  申请人：Aissaoui Hamed

  公开号：US20100222600A1

  公开（公告）日：2010-09-02

  The invention relates to novel azetidine compounds of formula (I), wherein R 1 , R 2 , and X are as described in the description and their use as orexin receptor antagonists.

  这项发明涉及一种新型的式(I)的氮杂环丙烷化合物，其中R1、R2和X如描述中所述，并且它们作为促进睡眠的药物受体拮抗剂的用途。
• 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
  申请人：Aissaoui Hamed

  公开号：US20100016401A1

  公开（公告）日：2010-01-21

  The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R 1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.

  这项发明涉及式(I)的3-aza-双环[3.1.0]己烷衍生物，其中A、B、n、X和R1如描述中所述，以及其盐，以及它们作为促进睡眠的荷尔蒙受体拮抗剂的用途。